Silicon Valley-Based Electronics Manufacturer Selects Sacramento For Major Manufacturing Facility
March 25, 2016
NRC Manufacturing, a Fremont-based electronics manufacturer, announced an agreement to build a 230,000-square-foot manufacturing and office facility in Elk Grove. The NRC project will employ manufacturing and support personnel.
Sacramento is the gateway to Silicon Valley, and is fast becoming California’s next technology hub. This facility will increase the region’s attraction of advanced manufacturing, while helping California retain businesses.
NRC Manufacturing produces electronic components used in telecommunications, medical, biotechnology, defense, and consumer applications.
“While the rest of the country is losing its manufacturing base, California and Silicon Valley in particular continue to generate new industries,” said Barry Broome, President and CEO of the Greater Sacramento Economic Council. “Because of the specialized nature of this kind of manufacturing, and the need to remain close to tech innovators, Greater Sacramento is the ideal location.”
With space at a premium and costs continuing to rise, building a project of this magnitude is nearly impossible in the Bay Area. Greater Sacramento is 90 minutes from Silicon Valley, allowing for a seamless integration with NRC’s Fremont headquarters. Elk Grove was able to provide the necessary space and services to attract NRC.
The Greater Sacramento area provides NRC with access to a perpetual stream of highly educated college students from a pool of over 219,000 within the region. UC Davis, UC Berkeley, Sacramento State, and a robust community college network led by the Los Rios Community College District and Sierra College fortify Greater Sacramento with a wide range of talent and skills.
The Greater Sacramento region also boasts a 42 percent millennial working-age population, higher than Seattle, Portland, San Francisco, or San Jose. Eighteen thousand people move to Sacramento from the Bay Area each year. Greater Sacramento is the number two relocation destination for millennials leaving the Bay Area, second only to Seattle.
By building this facility in California, NRC remains part of one of the world’s most robust economies. “California is one of the most profitable states in the country to do business. And the Sacramento region is where leading-edge, visionary companies like NRC succeed,” Broome said. “Sacramento is already making game-changing advances in the life sciences and leads the country in agribusiness innovation. Our manufacturing sector is poised to do the same thing.”
With its shared workforce of 208,000 people, Greater Sacramento and the Bay Area have always enjoyed a strong collaboration. San Francisco, San Jose, and Sacramento create an innovation corridor. NRC’s investment fortifies and strengthens this relationship.
“As the cost of living in the San Francisco Bay Area rises, it makes sense for manufacturing companies to look at the Sacramento region as a logic next step,” said Broome. “Greater Sacramento is a complementary marketplace.”
New data from the Federal Reserve Bank of St. Louis shows that the Greater Sacramento region has recovered all the jobs that it lost during the COVID-19 pandemic. For the first time in 30 years, the region recovered faster than California.
A new white paper from Greater Sacramento Economic Council (GSEC) and Newmark finds the Greater Sacramento region is on a major growth trajectory as investment, population increase and expanding opportunities for talent and education go into overdrive.
Leading medical device company to build Center for Excellence in Cellular Manufacturing in Greater Sacramento (Rancho Cordova)
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), in partnership with the City of Rancho Cordova and the Greater Sacramento Economic Council (GSEC), announced that the company is building a multi-million dollar, 35,500-square-foot Center for Excellence in Cellular Manufacturing in Rancho Cordova, a suburb of Greater Sacramento, to provide contract manufacturing services for cell therapies, including the one called “CAR-T cell therapy”, which could save the lives of many cancer patients just like Emily Whitehead.